Prospective Study
Copyright ©The Author(s) 2018.
World J Clin Cases. Dec 6, 2018; 6(15): 952-960
Published online Dec 6, 2018. doi: 10.12998/wjcc.v6.i15.952
Table 1 Schedule of bowel preparation
DayProcedure
Previous dayDietLow-fibre diet
After dinnerMagnesium citrate 50 g/180 mL + Sennoside 48 mg
Examination09:00Mosapride citrate 20 mg
Swallowing of CCE-2 capsule
Booster (1)1 L of low-volume PEG (MoviPrep) + 0.5 L water
Booster (2)1 L of low-volume PEG (MoviPrep) + 0.5 L water
Booster (3)Magnesium Citrate 50 g/180 mL
Table 2 Patients’ characteristics n (%)
Numbers of patients30
Gender (male/female)18/12
Age [mean ± SD (range), yr]48.6 ± 13.3 (24-67)
Disease duration [mean ± SD (range), yr]13.9 ± 9.5 (1-32)
Inpatient/outpatient0/30
History of abdominal surgery2 (6.7)
Type of disease
Total colitis19 (63.3)
Left-sided10 (33.3)
Proctitis1 (3.3)
Disease activity (Rachmilewitz index)
CAI = 019 (63.3)
CAI = 14 (13.3)
CAI = 24 (13.3)
CAI = 32 (6.7)
CAI = 41 (3.3)
Serum albumin (mean ± SD, g/dL)4.2 ± 0.5
Serum CRP (mean ± SD, mg/dL)0.11 ± 0.15
Medications
5-ASA24 (80.0)
Steroid4 (13.3)
Thiopurines12 (40.0)
Anti-TNF-Ab1 (3.3)
No medication1 (3.3)
Observation period after CCE; median (range)20.5 (5-27)
Table 3 Performance of second generation of colon capsule endoscopy procedure
Total colon observation1, %93.3% (28/30)
Excretion within 8 h, %90.0% (27/30)
Capsule retention rate, %0% (0/30)
Mean transit time ± SD (range), min
Stomach27.2 ± 15.4 (4-63)
Small intestine72.7 ± 34.3 (23-155)
Colon2163.9 ± 211.0 (9-775)
Cecum and ascending colon50.4 ± 84.2 (1-386)
Transverse colon11.7 ± 17.6 (5-80)
Left-side colon2101.9 ± 186.3 (5-751)
Total time2263.8 ± 228.2 (54-952)
Total liquid volume of the examination day2329 ± 854 (500-3180)